A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2017 |
| Author/s |
author: Andrea Rubbert-Roth Gerd-Rüdiger Burmester Eduardo F Mysler Mariusz Korkosz Jiří Vencovský |
| Publication date | February 17, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |